ADC Linkers

抗体药物偶联物(ADC)由所需的单克隆抗体、活性细胞毒性药物和适当的连接子组成。抗体和细胞毒性药物之间的适当连接子提供了特定的桥梁,从而帮助抗体选择性地将细胞毒性药物递送至肿瘤细胞并准确地在肿瘤部位释放细胞毒性药物。除了偶联作用外,连接子在ADC的制备和储存阶段以及体循环期间维持ADC的稳定性。

目前正在进行临床评估的ADC含有的连接子主要分为两类:可裂解和不可裂解。可裂解的连接子依赖于细胞内部的过程来释放毒素,例如在细胞质中还原、在溶酶体中暴露于酸性条件或被细胞内的特定蛋白酶裂解。不可裂解的接头需要 ADC 的抗体部分发生蛋白水解降解才能释放细胞毒性分子,而细胞毒性分子会保留接头和与抗体连接的氨基酸。

接头的选择取决于靶标,基于对抗体-靶抗原复合物内化和降解的了解,以及偶联物的临床前体外和体内活性比较。此外,接头的选择还受所用细胞毒素的影响,因为每种分子都有不同的化学约束,并且药物结构通常适合特定的接头。

Antibody-drug conjugates (ADCs) consist of a desirable monoclonal antibody, an active cytotoxic drug and an appropriate linker. An appropriate linker between the antibody and the cytotoxic drug provides a specific bridge, and thus helps the antibody to selectively deliver the cytotoxic drug to tumor cells and accurately releases the cytotoxic drug at tumor sites. In addition to conjugation, the linkers maintain ADCs’ stability during the preparation and storage stages of the ADCs and during the systemic circulation period.

The ADCs currently undergoing clinical evaluation contain linkers are mostly classified into two categories: cleavable and noncleavable. Cleavable linkers rely on processes inside the cell to liberate the toxin, such as reduction in the cytoplasm, exposure to acidic conditions in the lysosome, or cleavage by specific proteases within the cell. Noncleavable linkers require proteolytic degradation of the antibody portion of the ADC for release of the cytotoxic molecule, which will retain the linker and the amino acid by which it was attached to the antibody.

The selection of linker is target dependent, based on the knowledge of the internalization and degradation of the antibody-target antigen complex, and a preclinical in vitro and in vivo activity comparison of conjugates. Moreover, the choice of a linker is also influenced by which cytotoxin is used, as each molecule has different chemical constraints, and frequently the drug structure lends itself to a specific linker.

By Effects: Chemical (3)
共 1202种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(2-pyridyldithio)-PEG1-hydrazine

(2-pyridyldithio)-PEG1-hydrazine 是一种可降解 (cleavable) 的含 1 个单元 PEG 的 ADC linker,可用于合成抗体偶联活性分子 (ADC)。

111625-28-6
99.04%
(2-pyridyldithio)-PEG1-hydrazine
(2-pyridyldithio)-PEG4 acid

(2-pyridyldithio)-PEG4 acid 是一种可降解 (cleavable) 的含 4 个单元 PEG 的 ADC linker,可用于合成抗体偶联活性分子 (ADC)。

581065-93-2
97.78%
(2-pyridyldithio)-PEG4 acid
(2-Pyridyldithio)-PEG6 acid

2-Pyridyldithio-PEG6 acid 是一种含 6 个单元 PEG 的可降解 (cleavable) ADC linker,可用于合成抗体偶联活性分子 (ADC)。

(2-Pyridyldithio)-PEG6 acid
(2R,3S)-3-(tert-Butoxy)-2-4-ethyl-2,3-dioxopiperazine-1-carboxamidobutanoic acid

(2R,3S)-3-(叔丁氧基)-2-(4-乙基-2,3-二氧代哌嗪-1-甲酰胺基)丁酸是一种ADC连接子。

79276-23-6
(2R,3S)-3-(tert-Butoxy)-2-4-ethyl-2,3-dioxopiperazine-1-carboxamidobutanoic acid
(2R,3S)-Fmoc-Abu(3-N3)-OH

(2R,3S)-Fmoc-Abu(3-N3)-OH 是一种含叠氮基团的点击化学试剂,其叠氮基团可与含 Alkyne 基团的分子发生铜催化的叠氮-炔环加成反应(CuAAc),也可与含 DBCO 或 BCN 基团的分子发生环张力促进的炔-叠氮环加成反应(SPAAC)。

1932349-21-7
(2R,3S)-Fmoc-Abu(3-N3)-OH
(2R,4R)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate

N-Boc-cis-4-hydroxy-D-proline methyl ester 是一种不可降解 (non-cleavable) 的 ADC linker,用于合成抗体偶联活性分子 (ADCs),同时也是一种基于烷基链 (alkyl chain) 的 PROTAC linker,可用于合成 PROTAC。

114676-69-6
99.96%
(2R,4R)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate
(2R,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride

cis-4-Hydroxy-D-proline (hydrochloride) 是一种不可降解 (non-cleavable) 的 ADC linker,可用于合成抗体偶联活性分子 (ADCs),同时也是一种基于烷基链 (alkyl chain) 的 PROTAC linker,可用于合成 PROTAC。

77449-94-6
98.0%
(2R,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride
(2R,4R)-Boc-D-Pro(4-N3)-OH

(2R,4R)-Boc-D-Pro(4-N3)-OH 是一种含叠氮基的点击化学试剂,其 Azide 基团可与含 Alkyne 基团的分子发生铜催化的叠氮-炔环加成反应(CuAAc),也可与含 DBCO 或 BCN 基团的分子发生环张力促进的炔-叠氮环加成反应(SPAAC)。

650601-59-5
(2R,4R)-Boc-D-Pro(4-N3)-OH
(2R,4R)-Fmoc-D-Pro(4-N3)-OH
cis-4-Azido-N-Fmoc-D-proline

(2R,4R)-Fmoc-D-Pro(4-N3)-OH(cis-4-Azido-N-Fmoc-D-proline)是一种含有叠氮基团的点击化学试剂,其叠氮基团可与含Alkyne基团的分子发生铜催化的叠氮-炔环加成反应(CuAAc),也可与含DBCO或BCN基团的分子发生环张力促进的炔-叠氮环加成反应(SPAAC)。

1378847-51-8
98.73%
(2R,4R)-Fmoc-D-Pro(4-N3)-OH
(2R,4R)-H-D-Pro(4-N3)-OH hydrochloride

(2R,4R)-H-D-Pro(4-N3)-OH (hydrochloride) 是一种含有叠氮基团的点击化学试剂,其叠氮基团可与含 Alkyne 基团的分子发生铜催化的叠氮-炔环加成反应(CuAAc),也可与含 DBCO 或 BCN 基团的分子发生环张力驱动的炔-叠氮环加成反应(SPAAC)。

2737202-69-4
(2R,4R)-H-D-Pro(4-N3)-OH hydrochloride
(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid

N-tert-Butoxycarbonyl-trans-4-hydroxy-D-proline 是一种不可降解 (non-cleavable) 的 ADC linker,用于合成抗体偶联活性分子 (ADCs),同时也是一种基于烷基链 (alkyl chain) 的 PROTAC linker,可用于合成 PROTAC。

147266-92-0
98.0%
(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid
(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate

Boc-trans-D-Hyp-OMe 是一种不可降解 (non-cleavable) 的 ADC linker,可用于合成抗体偶联活性分子 (ADCs),同时也是一种基于烷基链 (alkyl chain) 的 PROTAC linker,可用于合成 PROTAC。

135042-17-0
98.0%
(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础